|
|
GlaxoSmithKline plc (GSK) is a global healthcare group, which is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products, including vaccines, over-the-counter (OTC) medicines and health-related consumer products. GSK?s principal pharmaceutical products include medicines in the therapeutic areas, such
as respiratory, central nervous system, anti-virals, anti-bacterials, metabolic, vaccines, cardiovascular and urogenital, oncology and emesis. It has operations in some 114 countries and products sold in over 150 countries. The Company operates in two segments: Pharmaceuticals (prescription pharmaceuticals and vaccines) and Consumer Healthcare. On October 14, 2008, it acquired the Egyptian mature products business of Bristol Myers Squibb Company (BMS). In July 2009, BMS' branded generics business, which comprises a portfolio of 13 branded pharmaceuticals was acquired by the Company. In July 2009, GSK acquired Stiefel Laboratories, Inc.
.
( Total: 14 Current Stock Recommendations )
|
|
|
|
|
|
|
|
|
|
* As of 5/24/2013 12:00 AM
|
|
|
|
|